Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial ...

21 August 2026 · By · Wire by Fusion42

Published

21 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at appliedclinicaltrialsonline.com →

◆ Verified

Fusion42 · 22 August 2026 · Fusion42 review

Clinical trial failures are increasingly attributed to administrative problems; consolidation among contract research organizations (CROs) is accelerating to expand global trial reach, alongside FDA approval of the first treatment for fibrodysplasia ossificans progressiva (FOP).

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You face a direct challenge in trial management as administrative hurdles rise and CROs consolidate power. Now is the time to forge partnerships with larger CROs or build in-house capabilities that bypass these bottlenecks.

◆ Coverage

1 source · 21 Aug 2026

◆ Related on Wire

◆ Topics

Medtechclinical-trialscro-consolidationfda-approvaladministrative-challenges